Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody.
Ontology highlight
ABSTRACT: Monoclonal antibodies targeting GD2 ganglioside (GD2) have recently been approved for the treatment of high risk neuroblastoma and are extensively evaluated in clinics in other indications. This study illustrates how a therapeutic antibody distinguishes between different types of gangliosides present on normal and cancer cells and informs how synthetic peptides can imitate ganglioside in its binding to the antibody. Using high resolution crystal structures we demonstrate that the ganglioside recognition by a model antibody (14G2a) is based primarily on an extended network of direct and water molecule mediated hydrogen bonds. Comparison of the GD2-Fab structure with that of a ligand free antibody reveals an induced fit mechanism of ligand binding. These conclusions are validated by directed
SUBMITTER: Horwacik I
PROVIDER: S-EPMC4597138 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA